Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("TOPOLCAN, O")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 30

  • Page / 2
Export

Selection :

  • and

SOME PROBLEMS OF RADIOIMMUNOASSAY CONTROLZAVADA M; SAFARCIK K; TOPOLCAN O et al.1978; J. RADIOANAL. CHEM.; CHE; DA. 1978; VOL. 46; NO 1; PP. 57-66; BIBL. 30 REF.Article

RETINAL MICROANGIOPATHY IN CORONARY HEART DISEASE WITHOUT OVERT DIABETES.SIMON J; KARLICEK V; TOPOLCAN O et al.1977; AMER. HEART J.; U.S.A.; DA. 1977; VOL. 96; NO 1; PP. 130-131; BIBL. 7 REF.Article

Tissue concentration of cytokines in kidneys from non-heart beating donorsTRESKA, V; HASMAN, D; TOPOLCAN, O et al.Transplantation proceedings. 2001, Vol 33, Num 7-8, pp 3747-3749, issn 0041-1345Article

INFEKCE HEPATITIDOU TYPU B U SVERENCU AZAMESTNANCU USTAVU SOCIALNI PECE = INFECTION PAR LE VIRUS DE L'HEPATITE B CHEZ LES ENFANTS ET LES EMPLOYES D'INSTITUT DE PROTECTION SOCIALEFARNIK J; HAVLOVIC J; BERANOVA D et al.1978; CESKOSL. EPIDEMIOL. MIKROBIOL. IMUNOL.; CSK; DA. 1978; VOL. 27; NO 4; PP. 212-217; ABS. RUS/ENG; BIBL. 13 REF.Article

Proliferative markers in diagnosis of thyroid tumors : A comparative study of MIB-1 and topoisomerase II-α immunostainingLUDVIKOVA, M; HOLUBEC, L. JR; RYSKA, A et al.Anticancer research. 2005, Vol 25, Num 3A, pp 1835-1840, issn 0250-7005, 6 p.Article

Preoperative Tumor Markers as Prognostic Factors of Colorectal Liver MetastasesTRESKA, V; TOPOLCAN, O; STANISLAV, K et al.Hepato-gastroenterology. 2009, Vol 56, Num 90, pp 317-320, issn 0172-6390, 4 p.Article

The importance of prognostic factors in premenopausal women with breast cancerFINEK, J; HOLUBEC, L; TOPOLCAN, O et al.Anticancer research. 2007, Vol 27, Num 4A, pp 1893-1896, issn 0250-7005, 4 p.Conference Paper

Markers of cellular adhesion in diagnosis and therapy control of colorectal carcinomaHOLUBEC, L. JR; TOPOLCAN, O; SVOBODOVA, S et al.Anticancer research. 2005, Vol 25, Num 3A, pp 1597-1601, issn 0250-7005, 5 p.Article

Tumor markers in pleural effusionsTOPOLCAN, O; HOLUBEC, L; FINEK, J et al.Anticancer research. 2007, Vol 27, Num 4A, pp 1921-1924, issn 0250-7005, 4 p.Conference Paper

Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samplesPESTA, M; HOLUBEC, L. JR; CERNY, R et al.Anticancer research. 2005, Vol 25, Num 5, pp 3387-3391, issn 0250-7005, 5 p.Article

Criteria for the selection of referential groups in tumor marker statistical evaluation on the basis of a retrospective studyHOLUBEC, L. JR; TOPOLCAN, O; PIKNER, R et al.Anticancer research. 2003, Vol 23, Num 2A, pp 865-870, issn 0250-7005, 6 p.Conference Paper

Cytokeratin Serum Biomarkers in Patients with Colorectal CancerHOLDENRIEDER, S; STIEBER, P; LISKA, V et al.Anticancer research. 2012, Vol 32, Num 5, pp 1971-1976, issn 0250-7005, 6 p., bConference Paper

Importance of miR-20a Expression in Prostate Cancer TissuePESTA, M; KLECKA, J; HOLUBEC, L et al.Anticancer research. 2010, Vol 30, Num 9, pp 3579-3583, issn 0250-7005, 5 p.Article

Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in Lung Tissue of Patients with Non-small Cell Lung Cancer (NSCLC) and Benign Pulmonary DiseaseSAFRANEK, J; PESTA, M; HOLUBEC, L et al.Anticancer research. 2009, Vol 29, Num 7, pp 2513-2517, issn 0250-7005, 5 p.Article

Clinical relevance of tumor markers for the control of chemotherapyFINEK, J; HOLUBEC, L. JR; VISOKAI, V et al.Anticancer research. 2005, Vol 25, Num 3A, pp 1655-1658, issn 0250-7005, 4 p.Article

Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status reportDUFFY, M. J; STURGEON, C; LAMERZ, R et al.Annals of oncology. 2010, Vol 21, Num 3, pp 441-447, issn 0923-7534, 7 p.Article

Tumour markers in colorectal cancer : European Group on Tumour Markers (EGTM) guidelines for clinical useDUFFY, M. J; VAN DALEN, A; HAGLUND, C et al.European journal of cancer (1990). 2007, Vol 43, Num 9, pp 1348-1360, issn 0959-8049, 13 p.Article

Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790MJANCARIKOVA, D; PESEK, M; BENESOVA, L et al.Anticancer research. 2007, Vol 27, Num 4A, pp 1879-1882, issn 0250-7005, 4 p.Conference Paper

Tumor markers as useful predictors of survival rate after exploratory laparotomy for liver malignanciesLISKA, V; HOLUBEC, L; TRESKA, V et al.Anticancer research. 2007, Vol 27, Num 4A, pp 1887-1891, issn 0250-7005, 5 p.Conference Paper

Diagnostic role of markers dipeptidyl peptidase IV and thyroid peroxidase in thyroid tumorsKHOLOVA, I; LUDVIKOVA, M; RYSKA, A et al.Anticancer research. 2003, Vol 23, Num 2A, pp 871-875, issn 0250-7005, 5 p.Conference Paper

Differential Display Code 3 (DD3/PCA3) in Prostate Cancer DiagnosisKLECKA, J; HOLUBEC, L; STOLZ, J et al.Anticancer research. 2010, Vol 30, Num 2, pp 665-670, issn 0250-7005, 6 p.Article

Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastasesLISKA, V; HOLUBEC, L; TRESKA, V et al.Anticancer research. 2007, Vol 27, Num 4C, pp 2861-2864, issn 0250-7005, 4 p.Article

Dynamic monitoring of cardio-specific markers and markers of thyroid gland function in cancer patients : A pilot studyHOLUBEC, L; TOPOLCAN, O; FINEK, J et al.Anticancer research. 2007, Vol 27, Num 4A, pp 1883-1886, issn 0250-7005, 4 p.Conference Paper

TPS, thymidine kinase, VEGF and endostatin in cytosol of thyroid tissue samplesPIKNER, R; LUDVIKOVA, M; RYSKA, A et al.Anticancer research. 2005, Vol 25, Num 3A, pp 1517-1521, issn 0250-7005, 5 p.Article

Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancerSAFRANEK, J; HOLUBEC, L; TOPOLCAN, O et al.Anticancer research. 2007, Vol 27, Num 4C, pp 2953-2956, issn 0250-7005, 4 p.Article

  • Page / 2